South Dakota State University

Open PRAIRIE: Open Public Research Access Institutional
Repository and Information Exchange
South Dakota Swine Research Report, 2001

Animal Science Field Day Proceedings and
Research Reports

2002

The Effect of Diet and Oral Antibiotic Therapy on
Immune Function and Productivity in Young Pigs
C.C.L. Chase
South Dakota State University

D.J. Hurley
South Dakota State University

R.C. Thaler
South Dakota State University

T.E. Lucas
South Dakota State University

Follow this and additional works at: http://openprairie.sdstate.edu/sd_swinereport_2001
Part of the Animal Sciences Commons
Recommended Citation
Chase, C.C.L.; Hurley, D.J.; Thaler, R.C.; and Lucas, T.E., "The Effect of Diet and Oral Antibiotic Therapy on Immune Function and
Productivity in Young Pigs" (2002). South Dakota Swine Research Report, 2001. 25.
http://openprairie.sdstate.edu/sd_swinereport_2001/25

This Article is brought to you for free and open access by the Animal Science Field Day Proceedings and Research Reports at Open PRAIRIE: Open
Public Research Access Institutional Repository and Information Exchange. It has been accepted for inclusion in South Dakota Swine Research Report,
2001 by an authorized administrator of Open PRAIRIE: Open Public Research Access Institutional Repository and Information Exchange. For more
information, please contact michael.biondo@sdstate.edu.

i

SDSU

The effect of diet and oral antibiotic therapy on immune
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At 7 days of age, the pigs were vaccinated for
Mycoplasma hyopneumoniae (Respisure, Pfizer)
and the boars were castrated.
Prior to
vaccination, a 3 ml blood sample was collected.
At day 17-24 (weaning day), the pigs were re
vaccinated with M. hyopneumoniae and a 10 ml
blood sample was collected for cellular
immunological assays. Control pig diets were
managed
using
the
farm's
husbandry
procedures and all control creep and weaning
diets contained 40 grams/ton of Apralan ™.

Introduction
Medicated early weaning programs have
been shown to be an excellent method to control
disease incidence in the young pig. Additional
research by Oritz, et al', showed that early
weaning at 7-10 days without medication
resulted in significant weight gains over
conventional weaning at 14-17 days. We were.
interested in the effects of low levels of
conventional water and feed grade antibiotic
treatments on performance and immunological
parameters of the young pig in a commercial
operation.
Previously, we had tested this
treatment at a research facility and had shown
increased production and a decreased
polyclonal immunological response in the
treated animals 23 • The use of such a program
would be a benefit to producers who do not have
the production facilities that allowing for early
weaning (7-10 days) and/or multisite production.

The nursery facility was connected to the
farrowing facility via a hallway and consisted of
10 raised deck pens. Eight pens were divided in
1/2 and each pen contained 10 pigs.
Antibiotic Treatment and Nutrition
The treatment regimen consisted of feeding
400g/ton of Aureomycin™ in the gestation
lactation ration for 1 week before and 1 week
after farrowing. The baby pigs' water was
treated with water soluble Aureomycin™ to
deliver 10 mg/# body weight beginning day 2
post farrowing through day 9 post farrowing.
Auero-Sulmet ™ soluble was added to the pigs
drinking
water
at
rate
of
250 mg
chlortetracycline/250 mg sulfamethazine per
gallon from day 10 post farrowing through day
27-30 post farrowing (10 days postweaning).
rate
of
100 gm
ASP250 ™
at
a
Chlortetracycline/100 gm sulfamethazine/50 gm
penicillin per ton was used in the feed. The
control group was managed using the farm's
normal husbandry and feeding procedures and
all control creep and weaning diets contained
40 grams/ton of Apralan ™.

A study was conducted to determine the
effect of Aureomycin™ and Aureo-Sulmet™ on
production. The study was a 2X2 factorial
experiment to determine the effect of weaning
treatment and nutrition level on immune
response.
Experimental Procedure
Animals and Management: A commercial
150-head sow herd of known health status was
chosen for this trial. This is a herd whose health
status is monitored by Dr. Chase. The farrowing
facility is a remodeled barn containing 27 crates.
The crates and flooring had been replaced in the
last year. Pigs were processed at 1 day of age
(tails removed, iron dextran injections, needle
teeth clipped).

Sixteen litters (160 pigs) were randomly
assigned to one of 4 treatment groups:
1) Control Standard nutrition; 2) Control-High
nutrition; 3) Treatment-Standard nutrition and
4) Treatment High nutrition. Commercial diets
were utilized. Traditional phase I, II & Ill nursery
diets 1 were used for the standard feeding
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regime while the high feeding regime consisted
of pre-phase I (day 7 diet), phase I & phase II
1 Diet changes were made at 7 and 21 days
post weaning. There were 4 replicates/
treatment.
The pigs were weighed weekly
through day 56 post farrowing. All feed was
weighed to obtain feed efficiency data.

Results
Production: These results indicated a 4.5%
increase in daily gain of the treated vs the
control pigs on the standard nutrition program
and 13.6% increase in daily gain of the treated
vs controls on the high nutrttion program
(Table 1). Feed/gain was 9.6% lower for the
treated vs the control pigs on the standard
nutrition program. There was no significant
advantage in gain between the standard and
high nutrition program to offset the increased
cost of the high nutrition ration .. There was no
significant difference (P<.05) in any ·of the
parameters measured (Table 1).

Serology and Immunology
Pigs were bled at 7 days of age, 28-31 days
of age and 56-58 days of age for serology and
immunological assays. Lymph node cells were
harvested from the pigs sacrificed at day 56.
Serology was performed at Oxford Diagnostic
Laboratories, Worthington, MN using a
commercial M. hyopneumoniae ELISA.

Immunology

Mitogen proliferation assays were conducted
in the Clinical Immunology Laboratory SDSU.
The plant lectins, concanavalin A (ConA) at
1 µg/ml, phytohemagglutinin A (PHA) at 1 µg/ml
and pokeweed mitogen (PMA) at 5 µg/ml were
used to stimulate isolated peripheral blood
lymphocytes. The lymphocytes were cultured
for 44 hours and pulsed for 4 hours with
tritiated (3H) thymidine and harvested at 48 hrs
in a cell collector. The disks were counted in a
liquid scintillation counter. All cultures were
done in triplicate and the values represent the
mean specific incorporation (sample meanunstimulated cell mean) of the triplicate
samples.
Forced antibody production was
performed after the protocol of Hammerburg
et al'. Briefly, 1 ml of mononuclear cells at
3 X 106/ml were incubated in 12X75 mm sterile
plastic tubes containing 1 ml of RPMI with
10 µg/ml of PWM for 72 hours. The tubes were
centrifuged and the supernatant was collected.
The supernatant was diluted in a ten fold series
and a polyclonal-polyclonal sandwich capture
ELISA was used to measure the total amount of
immunoglobulin present.
The assay was
standardized with a preparation of porcine lgG
(Sigma, St. Louis, MO).

Thymus, spleen, and pulmonary and
abdominal lymph nodes were removed from
each group. Identification of thymic tissue and
the variability in of the number of lymph nodes
made accurate analysis of these immune organs
difficult. There was no significant difference in
the lymph nodes and the spleen (Table 2).
Spleens were consistently smaller in the treated
vs the control pigs (Table 2). There were no
gross lesions present in any of the pigs.
Serology indicated a single statistical
significant difference between the controlstandard nutrition group and the treatmentstandard nutrition group at day 56 (Table 3).
The entire group had pre-immunization antibody
to M. hyopneumoniae (Table 3). All groups of
pigs developed higher antibody titers following
immunization and a majority (>60%) of each
group responded. The antibody decay was
much faster in the treated pigs (Table 3).
The ConA and PHA mitogenic assays were
used to measure the immunological capacity of
peripheral blood T cells (PBL)(Figure 1 A & B).
There was no statistical significant difference
between any of the groups at either day 28 or
day 56. The trend of this experiment was that
the pigs fed the standard diet had a higher
immune activation throughout the trial (Figure 1
A& B).

At day 56, 1O pigs from each group were
transported to the Diagnostic Laboratory at
South
Dakota
State University (SDSU)
euthanized and necropsied.
The spleen,
thymus, abdominal and lung lymph nodes were
removed and weighed.

T and B cell mitogenic assays were also
used to assess lymph node cells (Figure 2).
These studies differed from the PBL studies in
that the treated pigs and in particular the
treatment-standard group consistently had
higher activation to both T and B cell mitogens
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age when treated under the Cyanamid oral
protocol. All the animals in the study produced
similar amounts of antibody at 56 days. This
level was equivalent to that produced by the
treated pigs at 28 days. This suggests that the
treated animals could mount a competent
antibody response by the day 28, but it took
longer for the control animals to achieve a
similar capacity.

(Figure 2). There was no statistical significant
difference among any of the groups.
The
proliferative B cell capacity was ·measured
following stimulation with PWM (Figure 3). The
treatment pigs under both sets of nutritional
conditions had higher level of proliferative
response. There was no statistically significant
difference b.etween any of the groups at either
day 28 or day 56. The ability of the ·cells to
produce antibody was measured in a PWM
forced antibody test (Figure 4 ). At day 28, the
treated animals had higher antibody production.
However by 56 days, there was no difference
between groups.
There was no ·statistical
significant difference among any of the groups at
day 28.

We found that treated animals had a
generally higher capacity to respond to both T
and B cell stimulation in lymph node cells. This
may reflect a more complete development of
secondary lymphoid tissue in the treated pigs.
The major role of secondary lymphoid tissue is
the organized expansion of activated clones. A
well organized lymph node should contain a
near optimal ratio of antigen presenting cells,
helper cells and T and B effector cells. This
allows for the most efficient antigen specific
responses in an animal.
The polyclonal
stimulators used in this study measure the
overall capacity to mount a proliferative
response by the cells in the culture. The
increased responsiveness here suggests that
the protective immunological "environment" may
be more mature in the treated pigs. A more
efficient production of necessary cytokines or a
more optimal ratio of antigen presenting cells,
helper cells and effector cells (that go on to
proliferate) would yield higher rates of
proliferation.
We measured the weights of
thymus (a primary lymphoid organ) and spleen,
pulmonary and mesenteric lymph nodes
(secondary lymphoid organs). We found that
the mesenteric lymph nodes were apparently
more developed in the treated animals (Table 2).
The nodes were larger in treated. animals and
these nodes were used in the mitogen studies.
The pulmonary lymph nodes and spleens of the
animals were not different among the groups.
This is consistent with the proposed enteric
effect of the oral treatment and its ability to
promote quicker and more complete response to
enteric antigens. No clear effect on primary
lymphoid organs was expected. The control
animals with high nutrition had large thymus
compared to the other groups. The meaning of
this finding is not clear to us at this time.

Discussion
This trial showed that. low levels of
conventional water and feed grade antibiotic
treatment increased daily gain and lowered
feed/gain of young pigs in a commercial
environment. Although these changes were not
statistically significant, the study did show a 515% advantage in using oral antibiotics in
weaning pigs. The trend seen in this study was
consistent with the results obtained in our earlier
studies (Libal et al, 1994). On the basis of
improved growth and feed efficiency alone, the
minimal cost of this supplementation was clearly
justified (Libal et al, 1994).
The immunological result~ of this study were
very interesting. In our initial study (Libal et al.,
1994), we found that animals receiving the oral
medication program had less peripheral T cell
response capacity (demonstrated by lectin
responses) and greater B cell response capacity
(demonstrated by response to Pokeweed
Mitogen). In this study, similar results were
obtained, but the variability of the control and
treated pigs was great enough so that we did not
find these differences to be statistically
significant. In addition to the basic peripheral
blood mitogen assays performed in the first
study,
we
also
tested
several
other
immunological
parameters.
We
tested
pokeweed mitogen "forced production" of
antibody by multiple clones of B cells, responses
of lymph node mononuclear cells to the T and
B cell mitogens and specific humeral responses
to M. hyopneumoniae vaccine. As would be
predicated from our B cell proliferation data, the
animals were able to produce a large quantity of
antibody from peripheral ·B cells at 28 days of

The specific immune response to the M.
occurred in all animals. The
duration of antibody titers was significantly
shorter in the treatment group than the controls
(Table ,3). This may reflect an "environment"
hyopneumoniae
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vaccination reactivation period. The very low
cost of this supplementation in the water and of
the treatment of the sow are easily justified by
the approximately 10% enhancement in growth.
The herd in which this study was conducted was
of reasonably high health status and there was
little room for improvement in general health
related growth. We feel that a lower health
status herd would have had a greater level of
difference in both growth and measured
immunological
activation.
Chronically
challenged animals are at a higher state of
"inflammatory ready" than better managed
herds. This allows for greater effect of the
antibiotic supplementation in controlling the level
and duration of enteric challenge and post
challenge colonization.

less conducive to collateral stimulation in the
treated pigs. The treated pigs showed a greater
overall capacity to make antibody than the
controls, but in this case, where no exposure to
antigen after vaccination was indicated, they did
not persist in producing high levels.
We
interpret these results as a redirection of
resources into the growth of the pigs away from
a sustained inflammatory response, which
promotes an extended production of antibody no
longer sustained by the presence of antigen
stimulation. The differences in mucosal lymph
node maturation may also play a role here. If
optimal levels of antigen clearance and antibody
production were reached earlier in treated
animals, the need for further response would be
removed and the control animals may just be
slower in their overall. responses.

We would recommend further studies of the
comparative development of the secondary
immune organs. A special emphasis should be
place on the development of mucosal immune
capacity and diversity.
Some measures of
general inflammatory state on mucosal surfaces
and in systemic responses may also be
valuable. We believe that the immune system
develops better if the diversity of exposure is
great, but the challenge load is limited. MEW
programs have been successful because the
systemic medications controlled the level of
challenge in the respiratory tract. However, they
are flawed in that they eliminated a broad
diversity of exposure. This Cyanamid oral
supplementation technique is better because it
manages the total challenge exposure without
reducing the diversity of exposure needed to
successful development of a mature, functional
immune system.

These studies offered further evidence that
management of the enteric and respiratory
"environment" with the use of oral antibiotics as
weaning supplement enhances feed utilization,
growth and appears to improve the development
of the secondary immune tissues. The treated
animals had a small, but reasonable
improvement in their ability to mount a humeral
immune response. Evidence that the effect was
most pronounced in the mucosal compartment
included the differences seen between treated
and control animals in lymph node development,
ability to produce near optimal levels of antibody
at a younger age, apparent enhancement of the
activation environment with cells from the
mesenteric lymph nodes tested, and a rapid
peak and reduction in the antibody response to
H. hyopneumoniae in the treated animals
compared to the controls which had a much
more prolonged rise in titer and a longer post
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TABLE 1. TRIAL 1-WEANING PERFORMANCE (DAYS 17-56)
Control
Std 1 Nutrition
0.768
1.488
1.913
91.25

Daily Gain, lbs•
Daily Feed, lbs"
Feed/Gain"
Survival, %a
'Standard
'P=.0774
'P=.6106
'P=.1430
'P=.3095

Control
High Nutrition
0.748
1.163
1.568
100.00

Treatment
Std' Nutrition
0.803
1.380
1.728
98.00

Treatment
High Nutrition
0.850
1.388
1.620
100.00

TABLE 2. IMMUNOLOGICAL TISSUE WEIGHT (GRAMS)
Control
Std' Nutrition
1.81
29.16
0.79
2.81

Treatment
1
Std Nutrition
2.49
27.65
0.76
3.41

Thymus,)(
Spleen, g
Pulmonary LN2, g•
Mesenteric LN2, gd
'Standard 2 Lymph node
'P=0.0008 but Diet Weaning Regime significant at P=0.0084.
'P=0.400
'P=0.185
'P=0.190

Control
High Nutrition
6.22
32.79

1.17
2.70

Treatment
High Nutrition
2.71
27.93
0.81
4.19

TABLE 3. SEROLOGICAL TITER (LOG10) TO MYCOPLASMA
HYOPNEUMONIAE
(number of pigs seropositive/total number of pigs tested)
Days of age

Control
Std' Nutrition
1.18±1.25 (5/10J
2.33±1.27 (8/10J
2.18±1.27 (7/9)

Treatment
Std 1Nutrition
0.56±1.18 (2/10J
2.14±1.51 (7/10J
0.22±0.67 (1/10)

Control
High Nutrition
0.89±1 ..16 (4/1 OJ
1.82±1.59 (6/1 OJ
1 .44±1 .41 (5/9)

Day?
Day28
Day 55•
'Standard
'Treatment Std Nutrition is different from Control Std Nutrition (P<.001 J
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Treatment
High Nutrition
1,08±1.40 (4/10J
2.02±1.11 (8/10J
0.83±1.34 (3/10)

